Skip to content
Altius – Lifestyle
Author:
REPROCELL Inc.
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
June 24, 2026